The unit price of Serplulimab generally ranges from US$$290 to U$$724. The specific price is subject to factors including region, dosage, medical insurance policies and purchasing channels, and shall be finalized by the actual medical institution where the drug is purchased.
As a prescription drug, Serplulimab requires a professional doctor to evaluate the patient’s condition and issue a prescription before use. Patients shall not purchase the drug or adjust the treatment regimen on their own.
Explanations of Price Influencing Factors
Regional Differences
Drug pricing may vary across provinces or cities, with slightly higher prices in some economically developed regions.
Dosage and Treatment Course
The total cost is directly affected by the dosage and treatment duration, which are determined based on the patient’s weight, severity of illness and other individual conditions.
Medical Insurance Reimbursement
Serplulimab has been included in the medical insurance catalog in some regions, and the out-of-pocket expenses can be significantly reduced after reimbursement. For details, consult the local medical insurance authority.
Patient Assistance Programs
Some pharmaceutical companies or charitable organizations offer medication subsidies or free-drug programs. Financially disadvantaged eligible patients can apply for relevant support.
Precautions for Medication
Strictly follow medical advice
Serplulimab must be used under the guidance of a doctor for its approved indications (e.g., non-small cell lung cancer, solid tumors, etc.), and shall not be used outside the approved scope.
Safety monitoring
During treatment, regular re-examinations of blood routine, liver and kidney functions and other indicators are required to detect immune-related adverse reactions (such as pneumonia, hepatitis, etc.) in a timely manner.
Storage conditions
Unopened vials shall be stored in a dark, refrigerated environment (2–8℃), avoiding freezing or vigorous shaking.
For further details on costs or personalized treatment plans, you are advised to directly contact the pharmacy department of your treating hospital or a qualified medical institution for accurate information.
